The obesity doctor takes on why some people see weaker results on GLP-1 medications. Short clip with few details given.
Recap by typeshit. Post by @drnadolsky on Instagram.
EMY covers findings suggesting GLP-1 drugs such as Wegovy could lower the risk of certain cancers. Details on which cancers are in the full story.
Shah points to research published September 2 in which older mice given semaglutide lived longer, with effects he says went beyond blood sugar control.
The review weighs weight and metabolic benefits in people with IBD against early lab hints of anti-inflammatory effects, and looks at what observational studies show so far.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
NewBeauty profiles the New York doctor, who says she began using GLP-1 drugs off-label for weight management about 20 years ago.
Men's Fitness looks at BPC-157 and stacked peptides, arguing that getting the dose right is only part of the picture. Only the headline is available so far.
Loading…